<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Allergy and Clinical Immunology Society (Singapore) &#187; Education</title>
	<atom:link href="http://acis.org.sg/category/education/feed/" rel="self" type="application/rss+xml" />
	<link>http://acis.org.sg</link>
	<description></description>
	<lastBuildDate>Thu, 23 Apr 2026 07:22:02 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.5</generator>
		<item>
		<title>ALLERGY ACTION PLAN</title>
		<link>http://acis.org.sg/allergy-action-plan/</link>
		<comments>http://acis.org.sg/allergy-action-plan/#comments</comments>
		<pubDate>Thu, 21 Jul 2022 00:37:28 +0000</pubDate>
		<dc:creator>acis-web</dc:creator>
				<category><![CDATA[Education]]></category>

		<guid isPermaLink="false">http://acis.org.sg/?p=1937</guid>
		<description><![CDATA[Adult Allergy Action plan Child Allergy Action plan]]></description>
				<content:encoded><![CDATA[<ul>
<li><a href="https://1drv.ms/b/s!AtsZ8IEEmmKlgdAp2kZqLd4RKwhBEQ" target="_blank">Adult Allergy Action plan</a></li>
<li><a href="https://1drv.ms/b/s!AtsZ8IEEmmKlgdAoRTuH47FUi32OuQ" target="_blank">Child Allergy Action plan</a></li>
</ul>
]]></content:encoded>
			<wfw:commentRss>http://acis.org.sg/allergy-action-plan/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>ALLERGEN IMMUNOTHERAPY</title>
		<link>http://acis.org.sg/allergen-immunotherapy/</link>
		<comments>http://acis.org.sg/allergen-immunotherapy/#comments</comments>
		<pubDate>Sat, 30 Sep 2017 01:37:28 +0000</pubDate>
		<dc:creator>acis-web</dc:creator>
				<category><![CDATA[Education]]></category>

		<guid isPermaLink="false">http://acis.org.sg/?p=1385</guid>
		<description><![CDATA[Allergen Immunotherapy in Allergic Rhinitis EAACI 2017 Guidelines EAACI Guidelines on allergy immunotherapy in IgE mediated food allergy 2018 ASCIA Position paper on Oral Immunotherapy for Food allergy]]></description>
				<content:encoded><![CDATA[<ul>
<li><a href="https://onlinelibrary.wiley.com/doi/epdf/10.1111/all.13317" target="_blank">Allergen Immunotherapy in Allergic Rhinitis EAACI 2017 Guidelines</a></li>
<li><a href="https://onlinelibrary.wiley.com/doi/epdf/10.1111/all.13319" target="_blank">EAACI Guidelines on allergy immunotherapy in IgE mediated food allergy 2018</a></li>
<li><a href="https://www.allergy.org.au/images/stories/pospapers/ASCIA_HP_OIT_Food_Allergy_2021.pdf" target="_blank">ASCIA Position paper on Oral Immunotherapy for Food allergy</a></li>
</ul>
]]></content:encoded>
			<wfw:commentRss>http://acis.org.sg/allergen-immunotherapy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Anaphylaxis</title>
		<link>http://acis.org.sg/anaphylaxis-2/</link>
		<comments>http://acis.org.sg/anaphylaxis-2/#comments</comments>
		<pubDate>Sat, 30 Sep 2017 01:35:55 +0000</pubDate>
		<dc:creator>acis-web</dc:creator>
				<category><![CDATA[Education]]></category>

		<guid isPermaLink="false">http://acis.org.sg/?p=1406</guid>
		<description><![CDATA[EAACI guideline: Anaphylaxis (2021 update) Anaphylaxis-a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis]]></description>
				<content:encoded><![CDATA[<ul>
<li><a href="https://onlinelibrary.wiley.com/doi/10.1111/all.15032" target="_blank">EAACI guideline: Anaphylaxis (2021 update)</a></li>
<li><a href="https://www.jacionline.org/article/S0091-6749(20)30105-6/fulltext#secsectitle0165" target="_blank">Anaphylaxis-a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis</a></li>
</ul>
]]></content:encoded>
			<wfw:commentRss>http://acis.org.sg/anaphylaxis-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Asthma</title>
		<link>http://acis.org.sg/asthma-2/</link>
		<comments>http://acis.org.sg/asthma-2/#comments</comments>
		<pubDate>Sat, 30 Sep 2017 01:34:44 +0000</pubDate>
		<dc:creator>acis-web</dc:creator>
				<category><![CDATA[Education]]></category>

		<guid isPermaLink="false">http://acis.org.sg/?p=1410</guid>
		<description><![CDATA[GINA 2021 : Global Strategy for Asthma Management and Prevention ACE Guidelines : Asthma &#8211; Optimising long-term management with inhaled corticosteroid]]></description>
				<content:encoded><![CDATA[<ul>
<li><a href="https://ginasthma.org/wp-content/uploads/2021/05/GINA-Main-Report-2021-V2-WMS.pdf" target="_blank">GINA 2021 : Global Strategy for Asthma Management and Prevention</a></li>
<li><a href="https://www.ace-hta.gov.sg/docs/default-source/acgs/asthma-management-(nov-2020).pdf" target="_blank">ACE Guidelines : Asthma &#8211; Optimising long-term management with inhaled corticosteroid</a></li>
</ul>
]]></content:encoded>
			<wfw:commentRss>http://acis.org.sg/asthma-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Biologics</title>
		<link>http://acis.org.sg/biologics/</link>
		<comments>http://acis.org.sg/biologics/#comments</comments>
		<pubDate>Sat, 30 Sep 2017 01:33:55 +0000</pubDate>
		<dc:creator>acis-web</dc:creator>
				<category><![CDATA[Education]]></category>

		<guid isPermaLink="false">http://acis.org.sg/?p=1123</guid>
		<description><![CDATA[EAACI Biologicals Guidelines—Recommendations for Severe Asthma EAACI Biologicals Guidelines &#8211; Omalizumab for the treatment of chronic spontaneous urticaria in children and in adults EAACI Biologicals Guidelines- Dupilumab for children and adults with moderate-to-severe atopic dermatitis Efficacy and safety of treatment &#8230; <a href="http://acis.org.sg/biologics/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
				<content:encoded><![CDATA[<ul>
<li><a href="https://onlinelibrary.wiley.com/doi/full/10.1111/all.14425" target="_blank">EAACI Biologicals Guidelines—Recommendations for Severe Asthma</a></li>
<li><a href="https://eaaci.org/images/EAACI_Biologicals_Guidelines_CU.pdf" target="_blank">EAACI Biologicals Guidelines &#8211; Omalizumab for the treatment of chronic spontaneous urticaria in children and in adults</a></li>
<li><a href="https://onlinelibrary.wiley.com/doi/abs/10.1111/all.14690" target="_blank">EAACI Biologicals Guidelines- Dupilumab for children and adults with moderate-to-severe atopic dermatitis</a></li>
<li><a href="https://onlinelibrary.wiley.com/doi/10.1111/all.14809" target="_blank">Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: A systematic review for the EAACI guidelines</a></li>
</ul>
]]></content:encoded>
			<wfw:commentRss>http://acis.org.sg/biologics/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Skin Allergy</title>
		<link>http://acis.org.sg/skin-allergy-2/</link>
		<comments>http://acis.org.sg/skin-allergy-2/#comments</comments>
		<pubDate>Sat, 30 Sep 2017 01:33:22 +0000</pubDate>
		<dc:creator>acis-web</dc:creator>
				<category><![CDATA[Education]]></category>

		<guid isPermaLink="false">http://acis.org.sg/?p=1414</guid>
		<description><![CDATA[JSA 2017 : Japanese guidelines for atopic dermatitis 2017&#160; EAACI 2016 : The deﬁnition, diagnostic testing, and management of chronic inducible urticarias – The EAACI/GA2LEN/EDF/UNEV consensus recommendations 2016 update and revision BSACI 2015 : BSACI guideline for the management of &#8230; <a href="http://acis.org.sg/skin-allergy-2/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
				<content:encoded><![CDATA[<ul>
<li>JSA 2017 : <a href="http://ac.els-cdn.com/S1323893016301721/1-s2.0-S1323893016301721-main.pdf?_tid=e824c010-7be0-11e7-897c-00000aacb361&amp;acdnat=1502159335_604bf7039c275628fff17201057e3638" target="_blank">Japanese guidelines for atopic dermatitis 2017</a>&nbsp;</li>
<li>EAACI 2016 : <a href="http://onlinelibrary.wiley.com/doi/10.1111/all.12884/epdf" target="_blank">The deﬁnition, diagnostic testing, and management of chronic inducible urticarias – The EAACI/GA2LEN/EDF/UNEV consensus recommendations 2016 update and revision</a></li>
<li>BSACI 2015 : <a href="http://onlinelibrary.wiley.com/doi/10.1111/cea.12494/epdf" target="_blank">BSACI guideline for the management of chronic urticaria and angioedema</a></li>
<li>AAAAI 2015 : <a href="https://www.aaaai.org/Aaaai/media/MediaLibrary/PDF%20Documents/Practice%20and%20Parameters/Contact-dermatitis-2015.pdf" target="_blank">Contact Dermatitis: A Practice Parameter</a></li>
<li>EAACI 2015 : <a style="font-weight: 300;" href="http://onlinelibrary.wiley.com/doi/10.1111/pai.12463/pdf" target="_blank">EAACI position paper for practical patch testing in allergic contact dermatitis in children</a></li>
</ul>
]]></content:encoded>
			<wfw:commentRss>http://acis.org.sg/skin-allergy-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Drug Allergy</title>
		<link>http://acis.org.sg/drug-allergy-2/</link>
		<comments>http://acis.org.sg/drug-allergy-2/#comments</comments>
		<pubDate>Sat, 30 Sep 2017 01:32:59 +0000</pubDate>
		<dc:creator>acis-web</dc:creator>
				<category><![CDATA[Education]]></category>

		<guid isPermaLink="false">http://acis.org.sg/?p=1408</guid>
		<description><![CDATA[Diagnosis and management of the drug hypersensitivity reactions in Coronavirus disease 19: An EAACI Position Paper EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs &#8230; <a href="http://acis.org.sg/drug-allergy-2/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
				<content:encoded><![CDATA[<ul>
<li><a href="Diagnosis and management of the drug hypersensitivity reactions in Coronavirus disease 19: An EAACI Position Paper" target="_blank">Diagnosis and management of the drug hypersensitivity reactions in Coronavirus disease 19: An EAACI Position Paper</a></li>
<li><a href="EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity" target="_blank">EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity</a></li>
<li><a href="https://www.jaci-inpractice.org/action/showPdf?pii=S2213-2198%2820%2930816-3" target="_blank">Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs</a></li>
<li><a href="https://pubmed.ncbi.nlm.nih.gov/31932268/" target="_blank">Spanish Guidelines for Diagnosis, Management, Treatment, and Prevention of DRESS Syndrome</a></li>
<li><a href="https://journals.sagepub.com/doi/10.1177/0310057X1704500504?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%20%200pubmed" target="_blank">Australian and New Zealand Anaesthetic Allergy Group Perioperative Anaphylaxis Investigation Guidelines</a></li>
<li><a href="https://www.jprasurg.com/article/S1748-6815(16)00079-6/fulltext" target="_blank">UK guidelines for the management of Stevens–Johnson syndrome/toxic epidermal necrolysis in adults 2016</a></li>
</ul>
]]></content:encoded>
			<wfw:commentRss>http://acis.org.sg/drug-allergy-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Eosinophilia</title>
		<link>http://acis.org.sg/eosinophilia/</link>
		<comments>http://acis.org.sg/eosinophilia/#comments</comments>
		<pubDate>Sat, 30 Sep 2017 01:31:46 +0000</pubDate>
		<dc:creator>acis-web</dc:creator>
				<category><![CDATA[Education]]></category>

		<guid isPermaLink="false">http://acis.org.sg/?p=1369</guid>
		<description><![CDATA[&#160; ICON paper WHO defined eosinophilic disorders 2015 update British Committee for Standards in Haematology 2017 guidelines for investigation and management of eosinophila United European Gastroentrology guidines on eosinophilic oesophagitis European Competence Network on Mastocytosis : Proposed diagnostic algorithm for &#8230; <a href="http://acis.org.sg/eosinophilia/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
				<content:encoded><![CDATA[<p>&nbsp;</p>
<ul>
<li><a href="https://waojournal.biomedcentral.com/track/pdf/10.1097/WOX.0b013e31827f4192?site=waojournal.biomedcentral.com" target="_blank">ICON paper</a></li>
<li><a href="http://onlinelibrary.wiley.com/doi/10.1002/ajh.24196/epdf" target="_blank">WHO defined eosinophilic disorders 2015 update</a></li>
<li><a href="http://onlinelibrary.wiley.com/doi/10.1111/bjh.14488/epdf" target="_blank">British Committee for Standards in Haematology 2017 guidelines for investigation and management of eosinophila</a></li>
<li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5415218/pdf/10.1177_2050640616689525.pdf" target="_blank">United European Gastroentrology guidines on eosinophilic oesophagitis</a></li>
<li>European Competence Network on Mastocytosis : <a href="http://onlinelibrary.wiley.com/doi/10.1111/all.12436/pdf" target="_blank">Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis</a></li>
<li>European Competence Network on Mastocytosis : <a href="http://www.jacionline.org/article/S0091-6749(15)01258-0/pdf" target="_blank">Classification on cutaneous manifestations in patients with mastocytosis</a></li>
<li><a href="http://onlinelibrary.wiley.com/doi/10.1111/all.12617/epdf" target="_blank">ENDA/EAACI 2015: Drug hypersensitivity in clonal mast cell disorders</a></li>
</ul>
<p>&nbsp;</p>
]]></content:encoded>
			<wfw:commentRss>http://acis.org.sg/eosinophilia/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FOOD ALLERGY</title>
		<link>http://acis.org.sg/food-allergy-2/</link>
		<comments>http://acis.org.sg/food-allergy-2/#comments</comments>
		<pubDate>Sat, 30 Sep 2017 01:30:51 +0000</pubDate>
		<dc:creator>acis-web</dc:creator>
				<category><![CDATA[Education]]></category>

		<guid isPermaLink="false">http://acis.org.sg/?p=1381</guid>
		<description><![CDATA[Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management  Japanese guidelines for food allergy 2020 Peanut allergy diagnosis: A 2020 practice parameter update, systematic review, and GRADE analysis (AAAAI) Egg allergy 2021 (BSACI) Primary Prevention of &#8230; <a href="http://acis.org.sg/food-allergy-2/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
				<content:encoded><![CDATA[<ul>
<li><a title="Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management " href="https://www.jacionline.org/article/S0091-6749(17)31794-3/fulltext" target="_blank">Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management </a></li>
<li><a title="Japanese guidelines for food allergy 2020" href="https://reader.elsevier.com/reader/sd/pii/S1323893020300368?token=D746C81A1595D3B6703869820BF8ED26942A58C470B36AD188D6D1CDB5CA3060FF11A60328A99376CDD657968A3D5BF4&amp;originRegion=eu-west-1&amp;originCreation=20211028043452" target="_blank">Japanese guidelines for food allergy 2020</a></li>
<li><a title="Peanut allergy diagnosis: A 2020 practice parameter update, systematic review, and GRADE analysis (AAAAI)" href="https://www.aaaai.org/Aaaai/media/Media-Library-PDFs/Allergist%20Resources/Statements%20and%20Practice%20Parameters/PIIS0091674920311374.pdf" target="_blank">Peanut allergy diagnosis: A 2020 practice parameter update, systematic review, and GRADE analysis (AAAAI)</a></li>
<li><a title="Egg allergy 2021 (BSACI)" href="https://www.bsaci.org/guidelines/bsaci-guidelines/egg-allergy-2021/" target="_blank">Egg allergy 2021 (BSACI)</a></li>
<li><a title="•	Primary Prevention of Allergy n At-Risk Infants. AMS Consensus Statement Dec 2019" href="https://www.ams.edu.sg/view-pdf.aspx?file=media%5C5649_fi_819.pdf&amp;ofile=Consensus+Statement+on+Primary+Prevention+of+Allergy+in+At-Risk+Infants+(FINAL).pdf" target="_blank">Primary Prevention of Allergy n At-Risk Infants. AMS Consensus Statement Dec 2019</a></li>
</ul>
]]></content:encoded>
			<wfw:commentRss>http://acis.org.sg/food-allergy-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HAE</title>
		<link>http://acis.org.sg/hae/</link>
		<comments>http://acis.org.sg/hae/#comments</comments>
		<pubDate>Sat, 30 Sep 2017 01:29:46 +0000</pubDate>
		<dc:creator>acis-web</dc:creator>
				<category><![CDATA[Education]]></category>

		<guid isPermaLink="false">http://acis.org.sg/?p=1375</guid>
		<description><![CDATA[The International WAO/ EAACI Guideline for the Management of Hereditary Angioedema &#8211; the 2017 Revision and Update ASCIA HAE Position Paper and Management Plan&#160;]]></description>
				<content:encoded><![CDATA[<ul>
<li><a title="The International WAO/ EAACI Guideline for the Management of Hereditary Angioedema - the 2017 Revision and Update" href="https://waojournal.biomedcentral.com/articles/10.1186/s40413-017-0180-1" target="_blank">The International WAO/ EAACI Guideline for the Management of Hereditary Angioedema &#8211; the 2017 Revision and Update</a></li>
<li><a title="ASCIA HAE Position Paper and Management Plan" href="https://www.allergy.org.au/hp/papers/hereditary-angioedema" target="_blank">ASCIA HAE Position Paper and Management Plan&nbsp;
<p></a></li>
</ul>
]]></content:encoded>
			<wfw:commentRss>http://acis.org.sg/hae/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
